Possible Toxic Serotonin Syndrome in an Adolescent With Obsessive-Compulsive Disorder Precipitated by Esomeprazole

References (9)

1. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive-Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–1011. PubMed CrossRef
2. Naguy A. SSRIs-related behavioral syndromes in children and adolescents. J Can Acad Child Adolesc Psychiatry. 2016;25(2):69–70. PubMed
3. Preskorn SH. Drug-drug interactions (ddis) in psychiatric practice, part 6: pharmacodynamic considerations. J Psychiatr Pract. 2019;25(4):290–297. PubMed CrossRef
4. Naguy A, Abdelhamid HS, Elsori D, et al. Supramaximal dose of ecitalopram-associated hematuria in an adolescent with obsessive-compulsive disorder: a case report. J Clin Psychopharmacol. 2020;40(1):102–103. PubMed CrossRef
5. Dunkley EJC, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–642. PubMed CrossRef
6. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007;187(6):361–365. PubMed CrossRef
7. Badr B, Naguy A. Cyproheptadine: a psychopharmacological treasure trove? CNS Spectr. 2021:1–3. PubMed CrossRef
8. Naguy A, Abu-Zeid M. The oft-times overlooked “pharmacologic” relapse in schizophrenia. Australas Psychiatry. 2017;25(2):201–202. PubMed CrossRef
9. Naguy A. Psychotropic drugs and prolonged QTc interval: does it really that matter? Indian J Psychol Med. 2016;38(2):165–166. PubMed CrossRef